Usa covid-19 prevention Department Usa

US awards $450m contract to Regeneron for Covid-19 therapy supply

Reading now: 725
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Regeneron Pharmaceuticals has received a $450m contract from the US Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense for the manufacture and supply of its antibody cocktail therapy against Covid-19.

Named REGN-COV2, the double antibody cocktail is undergoing two Phase II / III clinical trials to treat Covid-19 patients, as well as a Phase III trial to prevent the disease.

Regeneron already began scaling up manufacturing of the therapy at business risk and this contract should support continued manufacturing.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA